marketcaparena
Search

    EBS

    Emergent BioSolutions Inc.

    Company overview

    Market capitalization
    $351.74M
    Employees
    900
    Latest publication
    2026-09-29
    About Emergent BioSolutions Inc.

    Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally. It operates through Commercial Products, MCM Products, and All Other Revenues segments. The company offers ACAM2000, a smallpox and mpox vaccine; Anthrax Immune Globulin Intravenous (ANTHRASIL), a polyclonal antibody therapeutic for the treatment of inhalational anthrax; Botulism Antitoxin Heptavalent (BAT), an equine plasma antitoxin for the treatment of symptomatic botulism; BioThrax, an anthrax vaccine; CYFENDUS, a vaccine for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis; Ebanga, a monoclonal antibody for the treatment of infection caused by Orthoebolavirus zairense; Raxibacumab injection, a monoclonal antibody therapeutic for the treatment and prophylaxis of inhalational anthrax due to Bacillus anthracis; TEMBEXA, an oral antiviral for the treatment of smallpox disease caused by variola virus in adult and pediatric patients; and CNJ-016, a polyclonal antibody therapeutic to address complications from smallpox vaccination. It also provides NARCAN and KLOXXADO nasal sprays for the emergency treatment of known or suspected opioid overdose. In addition, the company offers contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, analytical development, and suite reservation services. Emergent BioSolutions Inc. was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ3 20242024-09-30 · USDQ1 20242024-03-31 · USDQ1 20222022-03-31 · USD
    Total Revenue234,300,000USD156,100,000USD231,100,000USD140,900,000USD222,200,000USD293,800,000USD300,400,000USD307,500,000USD
    Cost Of Revenue97,100,000USD88,500,000USD102,000,000USD83,400,000USD105,700,000USD129,600,000USD159,600,000USD201,800,000USD
    Gross Profit137,200,000USD67,600,000USD129,100,000USD57,500,000USD116,500,000USD164,200,000USD140,800,000USD105,700,000USD
    Research Development9,200,000USD10,500,000USD13,500,000USD13,000,000USD15,200,000USD13,800,000USD15,100,000USD46,400,000USD
    Selling General Administrative44,600,000USD46,600,000USD38,900,000USD43,700,000USD52,400,000USD76,600,000USD84,700,000USD84,800,000USD
    Other Operating Expenses17,200,000USD———————
    Total Operating Expenses262,300,000USD57,100,000USD52,300,000USD57,000,000USD67,900,000USD99,700,000USD101,000,000USD99,300,000USD
    Operating Income-125,100,000USD10,500,000USD76,800,000USD500,000USD48,600,000USD64,500,000USD39,800,000USD6,400,000USD
    Total Other Income Expense Net-41,200,000USD2,900,000USD-19,200,000USD-17,300,000USD44,100,000USD77,900,000USD-27,700,000USD-10,200,000USD
    Interest Expense10,000,000USD11,000,000USD15,200,000USD14,700,000USD14,700,000USD8,300,000USD24,300,000USD8,200,000USD
    Income Before Tax-166,300,000USD13,400,000USD57,600,000USD-16,800,000USD92,700,000USD142,400,000USD12,100,000USD-3,800,000USD
    Income Tax Expense13,900,000USD6,600,000USD6,400,000USD-4,800,000USD24,700,000USD27,600,000USD3,100,000USD-100,000USD
    Net Income-180,200,000USD6,800,000USD51,200,000USD-12,000,000USD68,000,000USD114,800,000USD9,000,000USD-3,700,000USD
    Net Interest Income—-11,000,000USD-15,200,000USD-14,700,000USD-14,700,000USD-8,300,000USD-24,300,000USD-8,200,000USD
    Tax Provision—6,600,000USD6,400,000USD-4,800,000USD24,700,000USD27,600,000USD3,100,000USD-100,000USD
    Net Income From Continuing Ops—6,800,000USD51,200,000USD-12,000,000USD68,000,000USD114,800,000USD9,000,000USD-3,700,000USD
    Ebit—24,400,000USD72,800,000USD-2,100,000USD107,400,000USD72,000,000USD36,400,000USD6,900,000USD
    Ebitda—48,500,000USD96,600,000USD21,900,000USD133,400,000USD97,700,000USD63,400,000USD36,400,000USD
    Depreciation And Amortization—24,100,000USD23,800,000USD24,000,000USD26,000,000USD25,700,000USD27,000,000USD29,500,000USD
    Reconciled Depreciation—23,500,000USD23,400,000USD23,500,000USD25,400,000USD26,400,000USD27,900,000USD30,900,000USD
    Interest Income——15,200,000USD14,700,000USD14,700,000USD8,300,000USD—8,200,000USD
    Net Income Applicable To Common Shares——51,200,000USD-12,000,000USD68,000,000USD114,800,000USD—-3,700,000USD
    Unclassified Operating Expenses—————9,300,000USD1,200,000USD-31,900,000USD
    Non Operating Income Net Other———————-2,000,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USDFY 20162016-12-31 · USDFY 20152015-12-31 · USD
    Total Revenue742,900,000USD1,773,600,000USD1,577,300,000USD1,106,000,000USD782,400,000USD560,900,000USD488,800,000USD489,331,000USD
    Cost Of Revenue392,300,000USD980,400,000USD714,200,000USD622,900,000USD462,000,000USD277,300,000USD244,000,000USD216,845,000USD
    Gross Profit350,600,000USD793,200,000USD863,100,000USD483,100,000USD320,400,000USD283,600,000USD244,800,000USD272,486,000USD
    Research Development53,800,000USD235,200,000USD237,900,000USD226,200,000USD142,800,000USD97,400,000USD106,900,000USD119,186,000USD
    Selling General Administrative186,100,000USD347,500,000USD303,300,000USD273,500,000USD202,500,000USD143,497,000USD143,686,000USD148,458,000USD
    Total Operating Expenses240,400,000USD451,800,000USD424,600,000USD369,000,000USD230,600,000USD159,300,000USD139,300,000USD130,972,000USD
    Operating Income110,200,000USD341,400,000USD438,500,000USD114,100,000USD89,800,000USD124,300,000USD105,500,000USD141,514,000USD
    Interest Income59,300,000USD34,500,000USD31,300,000USD38,400,000USD9,900,000USD1,753,000USD1,053,000USD5,951,000USD
    Interest Expense59,300,000USD34,500,000USD31,300,000USD38,400,000USD9,900,000USD6,590,000USD7,617,000USD6,523,000USD
    Net Interest Income-59,300,000USD-34,500,000USD-31,300,000USD-38,400,000USD-9,900,000USD-4,837,000USD-6,564,000USD—
    Income Before Tax82,800,000USD303,200,000USD411,900,000USD77,400,000USD81,500,000USD118,600,000USD99,200,000USD135,716,000USD
    Income Tax Expense30,200,000USD83,700,000USD106,100,000USD22,900,000USD18,800,000USD36,000,000USD36,700,000USD44,300,000USD
    Tax Provision30,200,000USD83,500,000USD102,100,000USD22,900,000USD18,800,000USD36,039,000USD36,697,000USD44,300,000USD
    Net Income52,600,000USD219,500,000USD305,800,000USD54,500,000USD62,700,000USD82,600,000USD51,800,000USD62,870,000USD
    Net Income From Continuing Ops52,600,000USD230,900,000USD305,100,000USD100,300,000USD62,700,000USD82,594,000USD62,524,000USD62,870,000USD
    Ebit142,100,000USD386,000,000USD499,200,000USD150,900,000USD92,900,000USD132,100,000USD94,700,000USD151,341,000USD
    Ebitda240,400,000USD504,200,000USD609,200,000USD258,899,999USD155,100,000USD174,700,000USD132,900,000USD186,676,000USD
    Depreciation And Amortization98,300,000USD118,200,000USD110,000,000USD107,999,999USD62,200,000USD42,600,000USD38,200,000USD35,335,000USD
    Reconciled Depreciation95,800,000USD123,800,000USD114,500,000USD110,700,000USD62,200,000USD42,572,000USD——
    Total Other Income Expense Net-27,400,000USD-38,200,000USD-26,600,000USD-36,700,000USD-8,300,000USD-5,700,000USD-6,300,000USD-5,798,000USD
    Net Income Applicable To Common Shares52,600,000USD230,900,000USD305,100,000USD54,500,000USD62,700,000USD82,594,000USD51,776,000USD62,870,000USD
    Unclassified Operating Expenses—-130,900,000USD-116,600,000USD-130,700,000USD-114,700,000USD-81,597,000USD-111,286,000USD-136,672,000USD
    Non Operating Income Net Other—-3,700,000USD4,700,000USD1,700,000USD1,600,000USD938,000USD1,316,000USD253,000USD
    Discontinued Operations——————-10,748,000USD-28,546,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets1,116,800,000USD1,320,400,000USD1,318,600,000USD1,461,000,000USD1,417,100,000USD1,426,100,000USD1,396,900,000USD1,477,800,000USD
    Cash And Equivalents139,700,000USD—205,400,000USD245,500,000USD267,300,000USD149,100,000USD99,500,000USD149,900,000USD
    Total Current Assets666,000,000USD637,600,000USD662,500,000USD786,900,000USD719,500,000USD706,800,000USD598,700,000USD661,400,000USD
    Other Current Assets25,400,000USD28,100,000USD29,500,000USD35,600,000USD30,100,000USD40,000,000USD26,900,000USD67,500,000USD
    Other Non Current Assets11,000,000USD———————
    Total Liabilities775,400,000USD———————
    Total Current Liabilities122,800,000USD148,700,000USD132,199,999USD136,500,000USD127,100,000USD111,900,000USD162,400,000USD229,900,000USD
    Other Current Liabilities9,900,000USD———————
    Other Non Current Liabilities35,400,000USD———————
    Total Stockholder Equity341,400,000USD523,100,000USD522,600,000USD582,500,000USD536,200,000USD552,700,000USD482,800,000USD508,400,000USD
    Total Equity Including Noncontrolling Interest341,400,000USD———————
    Long Term Debt581,800,000USD573,600,000USD572,100,000USD663,100,000USD667,800,000USD665,700,000USD663,700,000USD661,800,000USD
    Deferred Revenue15,000,000USD———————
    Net Receivables190,000,000USD121,600,000USD84,200,000USD149,500,000USD79,800,000USD203,700,000USD154,500,000USD121,300,000USD
    Inventory303,600,000USD327,600,000USD343,400,000USD356,300,000USD338,600,000USD314,000,000USD311,700,000USD322,700,000USD
    Property Plant Equipment Net178,000,000USD199,400,000USD205,400,000USD209,800,000USD223,800,000USD221,000,000USD282,300,000USD290,500,000USD
    Intangible Assets261,800,000USD470,400,000USD436,500,000USD452,700,000USD469,000,000USD485,200,000USD501,500,000USD517,799,999USD
    Accounts Payable50,200,000USD39,500,000USD55,600,000USD57,400,000USD63,700,000USD58,100,000USD60,900,000USD82,100,000USD
    Common Stock100,000USD100,000USD100,000USD100,000USD100,000USD100,000USD100,000USD100,000USD
    Retained Earnings-333,200,000USD-153,000,000USD-159,800,000USD-105,200,000USD-156,400,000USD-144,400,000USD-212,400,000USD-181,100,000USD
    Accumulated Other Comprehensive Income-6,800,000USD-6,900,000USD-7,500,000USD-7,500,000USD-8,100,000USD-6,100,000USD-5,200,000USD-7,300,000USD
    Total Liab—797,300,000USD796,000,000USD878,500,000USD880,900,000USD873,400,000USD914,100,000USD969,400,000USD
    Other Current Liab—97,000,000USD76,599,999USD79,100,000USD56,700,000USD53,800,000USD94,000,000USD144,300,000USD
    Capital Stock—100,000USD100,000USD100,000USD100,000USD100,000USD100,000USD100,000USD
    Cash—160,300,000USD205,400,000USD245,500,000USD271,000,000USD149,100,000USD105,600,000USD149,900,000USD
    Cash And Short Term Investments—160,300,000USD205,400,000USD245,500,000USD271,000,000USD149,100,000USD105,600,000USD149,900,000USD
    Current Deferred Revenue—12,200,000USD——4,900,000USD—4,800,000USD—
    Net Debt—413,300,000USD366,700,000USD417,600,000USD405,100,000USD516,600,000USD570,500,000USD526,100,000USD
    Short Long Term Debt Total—573,600,000USD572,100,000USD663,100,000USD676,100,000USD665,700,000USD676,100,000USD676,000,000USD
    Property Plant Equipment Gross—509,400,000USD509,500,000USD500,500,000USD515,700,000USD517,800,000USD667,700,000USD671,900,000USD
    Common Stock Shares Outstanding—56,500,000shares52,400,000shares56,500,000shares54,200,000shares57,300,000shares54,200,000shares55,600,000shares
    Non Current Assets Total—682,800,000USD656,100,000USD674,100,000USD697,599,999USD719,300,000USD798,200,000USD816,400,000USD
    Non Current Liabilities Total—648,600,000USD663,800,000USD742,000,000USD753,800,000USD761,500,000USD751,700,000USD739,500,000USD
    Non Current Liabilities Other—41,700,000USD53,900,000USD42,600,000USD39,500,000USD35,400,000USD39,100,000USD35,800,000USD
    Non Currrent Assets Other—13,000,000USD14,200,000USD11,600,000USD4,799,999USD13,100,000USD7,200,000USD8,100,000USD
    Net Working Capital—488,900,000USD530,300,000USD650,400,000USD592,400,000USD594,900,000USD436,300,000USD431,500,000USD
    Unclassified Non Current Liabilities—33,300,000USD37,800,000USD36,300,000USD46,500,000USD60,400,000USD48,900,000USD41,900,000USD
    Unclassified Equity—682,800,000USD689,700,000USD695,000,000USD700,500,000USD703,000,000USD700,200,000USD696,600,000USD
    Other Assets——3,600,000USD4,400,000USD4,800,000USD6,500,000USD-7,200,000USD8,100,000USD
    Short Term Debt——0USD0USD1,800,000USD0USD2,700,000USD3,500,000USD
    Good Will———————1USD
    Short Long Term Debt———————800,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets1,318,600,000USD1,389,700,000USD1,823,200,000USD3,166,300,000USD2,957,700,000USD2,883,200,000USD2,327,300,000USD2,229,400,000USD
    Intangible Assets436,500,000USD501,500,000USD566,600,000USD728,800,000USD604,600,000USD663,100,000USD741,900,000USD811,600,000USD
    Other Current Assets29,500,000USD33,000,000USD47,900,000USD57,900,000USD70,200,000USD36,700,000USD20,400,000USD31,700,000USD
    Total Liab796,000,000USD906,900,000USD1,173,900,000USD1,778,600,000USD1,346,200,000USD1,436,200,000USD1,238,800,000USD1,218,500,000USD
    Total Stockholder Equity522,600,000USD482,800,000USD649,300,000USD1,387,700,000USD1,611,500,000USD1,447,000,000USD1,088,500,000USD1,010,900,000USD
    Other Current Liab76,599,999USD98,800,000USD125,400,000USD135,900,000USD196,000,000USD203,500,000USD105,100,000USD94,500,000USD
    Common Stock100,000USD100,000USD100,000USD100,000USD100,000USD100,000USD100,000USD100,000USD
    Capital Stock100,000USD100,000USD100,000USD100,000USD100,000USD100,000USD100,000USD100,000USD
    Retained Earnings-159,800,000USD-212,400,000USD-21,800,000USD738,700,000USD950,300,000USD726,900,000USD421,800,000USD367,300,000USD
    Other Assets3,600,000USD7,200,000USD178,100,000USD191,300,000USD-2,857,777,000USD115,000,000USD65,600,000USD27,100,000USD
    Cash205,400,000USD99,500,000USD111,700,000USD642,600,000USD576,300,000USD621,300,000USD168,000,000USD112,200,000USD
    Cash And Equivalents205,400,000USD99,500,000USD111,700,000USD642,600,000USD576,100,000USD621,300,000USD167,800,000USD112,200,000USD
    Cash And Short Term Investments205,400,000USD99,500,000USD111,700,000USD642,600,000USD576,300,000USD621,300,000USD168,000,000USD112,200,000USD
    Total Current Assets662,500,000USD598,700,000USD679,500,000USD1,210,400,000USD1,269,900,000USD1,195,900,000USD686,200,000USD620,800,000USD
    Total Current Liabilities132,199,999USD162,400,000USD651,300,000USD1,228,900,000USD374,000,000USD384,500,000USD216,300,000USD200,400,000USD
    Net Debt366,700,000USD576,600,000USD748,500,000USD783,800,000USD294,700,000USD301,700,000USD668,900,000USD682,400,000USD
    Short Term Debt0USD2,700,000USD413,700,000USD963,100,000USD37,400,000USD44,900,000USD16,399,999USD10,100,000USD
    Short Long Term Debt Total572,100,000USD676,100,000USD860,200,000USD1,426,400,000USD871,000,000USD923,000,000USD836,900,000USD794,600,000USD
    Long Term Debt572,100,000USD663,700,000USD446,500,000USD448,500,000USD809,400,000USD841,000,000USD798,400,000USD784,500,000USD
    Net Receivables84,200,000USD154,500,000USD191,000,000USD159,200,000USD278,900,000USD230,900,000USD275,300,000USD262,500,000USD
    Inventory343,400,000USD311,700,000USD328,900,000USD350,700,000USD344,500,000USD307,000,000USD222,500,000USD205,800,000USD
    Accounts Payable55,600,000USD60,900,000USD112,200,000USD103,500,000USD128,900,000USD136,100,000USD94,800,000USD80,700,000USD
    Property Plant Equipment Net205,400,000USD270,600,000USD399,000,000USD837,000,000USD828,400,000USD675,100,000USD567,000,000USD510,200,000USD
    Property Plant Equipment Gross509,500,000USD667,700,000USD794,200,000USD817,600,000USD800,100,000USD644,100,000USD542,300,000USD510,200,000USD
    Accumulated Other Comprehensive Income-7,500,000USD-5,200,000USD-5,700,000USD3,099,999USD-16,100,000USD-25,299,999USD-9,900,000USD-5,500,000USD
    Common Stock Shares Outstanding56,700,000shares53,000,000shares51,200,000shares50,100,000shares54,100,000shares53,800,000shares52,400,000shares51,400,000shares
    Non Current Assets Total656,100,000USD791,000,000USD1,143,700,000USD1,955,900,000USD1,687,799,999USD1,687,300,000USD1,641,100,000USD1,608,600,000USD
    Non Current Liabilities Total663,800,000USD744,500,000USD522,600,000USD549,699,999USD972,200,000USD1,051,700,000USD1,022,500,000USD1,018,100,000USD
    Non Current Liabilities Other53,900,000USD39,100,000USD28,900,000USD33,400,000USD61,900,000USD157,500,000USD160,200,000USD166,100,000USD
    Non Currrent Assets Other14,200,000USD18,900,000USD178,100,000USD171,900,000USD29,899,999USD82,400,000USD52,200,000USD13,700,000USD
    Net Working Capital530,300,000USD436,300,000USD28,200,000USD-19,200,000USD898,300,000USD811,400,000USD469,900,000USD420,400,000USD
    Unclassified Non Current Liabilities37,800,000USD41,700,000USD47,200,000USD-94,400,001USD-150,800,000USD-210,700,000USD-199,900,000USD-233,600,000USD
    Unclassified Equity689,700,000USD700,200,000USD676,600,000USD873,400,001USD829,300,000USD784,799,999USD716,000,000USD688,500,000USD
    Good Will——218,200,000USD218,200,000USD224,900,000USD266,700,000USD266,600,000USD259,700,000USD
    Current Deferred Revenue——26,400,000USD26,400,000USD11,700,000USD131,500,000USD101,900,000USD10,600,000USD
    Short Long Term Debt——413,700,000USD957,300,000USD31,600,000USD33,800,000USD12,900,000USD10,100,000USD
    Short Term Investments——8,500,000USD—————
    Unclassified Current Assets——-8,500,000USD————8,600,000USD
    Unclassified Non Current Assets——-396,300,000USD-191,300,000USD—-115,000,000USD-52,200,000USD—
    Unclassified Current Liabilities——-440,100,000USD-957,300,000USD-31,600,000USD-165,300,000USD-114,799,999USD-5,600,000USD
    Deferred Long Term Liab———71,800,000USD94,900,000USD53,200,000USD63,900,000USD67,500,000USD
    Other Liab———90,400,000USD156,800,000USD210,700,000USD199,900,000USD233,600,000USD
    Treasury Stock———-227,700,000USD-152,200,000USD-39,600,000USD-39,600,000USD-39,600,000USD
    Net Tangible Assets———1,383,000,000USD1,619,000,000USD1,447,000,000USD1,088,500,000USD1,010,900,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income6,800,000USD-54,600,000USD51,200,000USD-12,000,000USD68,000,000USD-31,300,000USD114,800,000USD-283,100,000USD
    Depreciation23,500,000USD23,500,000USD23,400,000USD23,500,000USD25,400,000USD26,000,000USD26,400,000USD28,500,000USD
    Stock Based Compensation1,900,000USD5,300,000USD4,800,000USD4,600,000USD1,500,000USD4,300,000USD2,300,000USD5,500,000USD
    Other Non Cash Items-9,700,000USD20,000,000USD9,900,000USD8,500,000USD-6,000,000USD6,800,000USD-62,700,000USD90,900,000USD
    Change To Account Receivables-38,900,000USD51,900,000USD-71,600,000USD118,500,000USD-73,300,000USD-77,100,000USD82,300,000USD20,400,000USD
    Change To Inventory15,800,000USD14,200,000USD-17,600,000USD-24,700,000USD-2,200,000USD11,000,000USD-18,000,000USD-13,000,000USD
    Change In Working Capital-51,800,000USD82,000,000USD-81,400,000USD95,700,000USD-118,700,000USD-85,300,000USD65,600,000USD205,900,000USD
    Total Cash From Operating Activities-33,800,000USD77,700,000USD-2,300,000USD106,400,000USD-11,200,000USD-79,900,000USD153,700,000USD47,500,000USD
    Capital Expenditures-2,400,000USD-3,900,000USD-3,400,000USD-2,900,000USD-3,600,000USD-1,700,000USD-5,800,000USD-4,600,000USD
    Free Cash Flow-36,200,000USD73,800,000USD-5,700,000USD103,500,000USD-14,800,000USD-81,600,000USD147,900,000USD42,900,000USD
    Total Cashflows From Investing Activities-2,400,000USD-3,900,000USD-3,400,000USD17,200,000USD59,500,000USD28,600,000USD112,000,000USD-4,600,000USD
    Total Cash From Financing Activities-11,400,000USD-113,900,000USD-15,900,000USD-6,400,000USD-400,000USD500,000USD-180,300,000USD-50,900,000USD
    Sale Purchase Of Stock-9,000,000USD-9,100,000USD-8,900,000USD-6,900,000USD100,000USD24,200,000USD600,000USD-200,000USD
    Change In Cash-47,600,000USD-40,100,000USD-21,800,000USD118,200,000USD47,200,000USD-50,800,000USD85,400,000USD-8,000,000USD
    Begin Period Cash Flow209,100,000USD249,200,000USD271,000,000USD152,800,000USD105,600,000USD156,400,000USD71,000,000USD79,000,000USD
    End Period Cash Flow161,500,000USD209,100,000USD249,200,000USD271,000,000USD152,800,000USD105,600,000USD156,400,000USD71,000,000USD
    Other Cashflows From Financing Activities-2,800,000USD-400,000USD-300,000USD-200,000USD-500,000USD-300,000USD4,400,000USD-200,000USD
    Unclassified Operating Cash Flow-4,500,000USD1,500,000USD-10,200,000USD-13,900,000USD18,600,000USD—7,300,000USD—
    Net Borrowings—-101,800,000USD-6,900,000USD0USD0USD0USD-194,000,000USD—
    Issuance Of Capital Stock—0USD———0USD9,300,000USD—
    Other Cashflows From Investing Activities—83,200,000USD83,200,000USD20,100,000USD63,100,000USD30,000,000USD117,800,000USD—
    Unclassified Investing Cash Flow—-83,200,000USD-79,800,000USD-17,200,000USD-59,500,000USD-28,300,000USD-112,000,000USD4,600,000USD
    Unclassified Financing Cash Flow—-2,600,000USD———-23,400,000USD8,700,000USD-50,500,000USD
    Investments——-3,400,000USD17,200,000USD59,500,000USD28,600,000USD112,000,000USD-4,600,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USD
    Net Income52,600,000USD-190,600,000USD-760,500,000USD-211,600,000USD305,800,000USD54,500,000USD62,700,000USD82,594,000USD
    Depreciation95,800,000USD108,800,000USD125,100,000USD143,300,000USD114,500,000USD110,700,000USD62,200,000USD42,572,000USD
    Stock Based Compensation16,200,000USD18,000,000USD23,100,000USD45,100,000USD51,800,000USD26,700,000USD23,200,000USD15,213,000USD
    Other Non Cash Items32,400,000USD39,300,000USD485,200,000USD19,800,000USD58,600,000USD39,600,000USD4,200,000USD10,777,000USD
    Change To Account Receivables25,500,000USD-24,400,000USD-21,600,000USD118,100,000USD27,500,000USD-8,200,000USD-94,200,000USD-4,810,000USD
    Change To Inventory-30,300,000USD-24,500,000USD600,000USD-57,100,000USD-66,900,000USD-16,700,000USD-1,900,000USD6,066,000USD
    Change In Working Capital-22,400,000USD88,700,000USD-70,300,000USD-2,100,000USD9,500,000USD-42,400,000USD-119,100,000USD53,724,000USD
    Total Cash From Operating Activities170,600,000USD58,700,000USD-206,300,000USD-34,100,000USD536,900,000USD188,000,000USD41,800,000USD208,139,000USD
    Capital Expenditures-13,800,000USD-22,900,000USD-51,600,000USD-115,800,000USD-141,900,000USD-86,900,000USD-72,100,000USD-54,828,000USD
    Free Cash Flow156,800,000USD35,800,000USD-257,900,000USD-149,900,000USD395,000,000USD101,100,000USD-30,300,000USD153,311,000USD
    Total Cashflows From Investing Activities69,400,000USD125,200,000USD212,300,000USD-381,300,000USD-151,900,000USD-96,900,000USD-897,200,000USD-249,932,000USD
    Net Borrowings-108,700,000USD-198,400,000USD-543,400,000USD564,200,000USD54,500,000USD13,700,000USD782,900,000USD-22,469,000USD
    Total Cash From Financing Activities-136,600,000USD-190,000,000USD-535,700,000USD481,200,000USD69,500,000USD-35,900,000USD788,700,000USD-51,401,000USD
    Sale Purchase Of Stock-24,900,000USD24,200,000USD-82,100,000USD-82,100,000USD-13,800,000USD-7,400,000USD-100,000USD-33,100,000USD
    Issuance Of Capital Stock0USD9,300,000USD8,400,000USD0USD————
    Change In Cash103,500,000USD-6,100,000USD-530,900,000USD66,300,000USD453,500,000USD55,600,000USD-66,900,000USD-93,221,000USD
    Begin Period Cash Flow105,600,000USD111,700,000USD642,600,000USD576,300,000USD168,000,000USD112,400,000USD179,300,000USD271,513,000USD
    End Period Cash Flow209,100,000USD105,600,000USD111,700,000USD642,600,000USD621,500,000USD168,000,000USD112,400,000USD178,292,000USD
    Other Cashflows From Investing Activities83,200,000USD148,100,000USD-6,300,000USD-265,500,000USD-10,000,000USD-10,000,000USD2,600,000USD-195,104,000USD
    Other Cashflows From Financing Activities-1,400,000USD-900,000USD-700,000USD-900,000USD6,600,000USD-49,600,000USD-6,400,000USD1,700,000USD
    Unclassified Operating Cash Flow-4,000,000USD-5,500,000USD-8,900,000USD-28,600,000USD——8,600,000USD3,259,000USD
    Unclassified Financing Cash Flow-1,600,000USD-14,900,000USD95,500,000USD—40,000,000USD8,199,999USD12,300,000USD2,468,000USD
    Investments—125,200,000USD178,300,000USD-381,300,000USD-151,000,000USD-96,900,000USD-897,200,000USD-249,932,000USD
    Unclassified Investing Cash Flow—-125,200,000USD91,900,000USD381,300,000USD151,000,000USD96,900,000USD69,500,000USD249,932,000USD
    Dividends Paid——-5,000,000USD—-17,800,000USD-799,999USD—0USD
    Change To Liabilities———-52,000,000USD61,000,000USD5,600,000USD-10,200,000USD36,131,000USD
    Cash And Cash Equivalents Changes———65,800,000USD454,500,000USD55,200,000USD-66,900,000USD-93,221,000USD
    Exchange Rate Changes——————-200,000USD-27,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30SegmentCommercial Products52,400,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30SegmentMCMProducts168,000,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31SegmentCommercial Products42,900,000USD0001367644-26-000065
    Q1 2026Quarterly · 2026-03-31SegmentMCMProducts101,800,000USD0001367644-26-000065
    Q4 2025Quarterly · 2025-12-31SegmentCommercial Products38,400,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentMCMProducts99,200,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentOther60,100,000USDLegacy provider
    FY 2025Yearly · 2025-12-31GeographyCanada75,000,000USD0001367644-26-000015
    FY 2025Yearly · 2025-12-31GeographyOther Geographical Area136,800,000USD0001367644-26-000015
    FY 2025Yearly · 2025-12-31GeographyUnited States531,100,000USD0001367644-26-000015
    FY 2025Yearly · 2025-12-31SegmentCommercial Products226,100,000USD0001367644-26-000015
    FY 2025Yearly · 2025-12-31SegmentMCMProducts456,700,000USD0001367644-26-000015
    FY 2025Yearly · 2025-12-31SegmentOther60,100,000USD0001367644-26-000015
    Q3 2025Quarterly · 2025-09-30SegmentCommercial Products74,900,000USD0001367644-25-000202
    Q3 2025Quarterly · 2025-09-30SegmentMCMProducts142,500,000USD0001367644-25-000202
    Q2 2025Quarterly · 2025-06-30SegmentCommercial Products67,500,000USD0001367644-25-000181
    Q2 2025Quarterly · 2025-06-30SegmentMCMProducts58,400,000USD0001367644-25-000181
    Q1 2025Quarterly · 2025-03-31SegmentCommercial Products45,300,000USD0001367644-26-000065
    Q1 2025Quarterly · 2025-03-31SegmentMCMProducts156,600,000USD0001367644-26-000065
    Q4 2024Quarterly · 2024-12-31SegmentCommercial Products65,100,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentMCMProducts116,800,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentOther134,900,000USDLegacy provider
    FY 2024Yearly · 2024-12-31GeographyCanada140,400,000USD0001367644-26-000015
    FY 2024Yearly · 2024-12-31GeographyOther Geographical Area80,600,000USD0001367644-26-000015
    FY 2024Yearly · 2024-12-31GeographyUnited States822,600,000USD0001367644-26-000015
    FY 2024Yearly · 2024-12-31SegmentCommercial Products398,900,000USD0001367644-26-000015
    FY 2024Yearly · 2024-12-31SegmentMCMProducts509,800,000USD0001367644-26-000015
    FY 2024Yearly · 2024-12-31SegmentOther134,900,000USD0001367644-26-000015
    FY 2024Yearly · 2024-12-31ProductCommercial Product398,900,000USD0001367644-25-000021
    FY 2024Yearly · 2024-12-31ProductContracts And Grants30,000,000USD0001367644-25-000021
    FY 2024Yearly · 2024-12-31ProductMedical Countermeasures MCMProduct509,800,000USD0001367644-25-000021
    FY 2024Yearly · 2024-12-31ProductService Member2,000,000USD0001367644-25-000021
    FY 2024Yearly · 2024-12-31ProductServices103,500,000USD0001367644-25-000021
    Q3 2024Quarterly · 2024-09-30SegmentCommercial Products95,300,000USD0001367644-25-000202
    Q3 2024Quarterly · 2024-09-30SegmentMCMProducts174,200,000USD0001367644-25-000202
    Q3 2024Quarterly · 2024-09-30ProductCommercial Product95,300,000USD0001367644-24-000178
    Q3 2024Quarterly · 2024-09-30ProductContracts And Grants10,000,000USD0001367644-24-000178
    Q3 2024Quarterly · 2024-09-30ProductMedical Countermeasures MCMProduct174,200,000USD0001367644-24-000178
    Q3 2024Quarterly · 2024-09-30ProductOther400,000USD0001367644-24-000178
    Q3 2024Quarterly · 2024-09-30ProductServices13,900,000USD0001367644-24-000178
    Q2 2024Quarterly · 2024-06-30ProductCommercial Product120,000,000USD0001367644-24-000147
    Q2 2024Quarterly · 2024-06-30ProductContracts And Grants6,600,000USD0001367644-24-000147
    Q2 2024Quarterly · 2024-06-30ProductMedical Countermeasures MCMProduct63,400,000USD0001367644-24-000147
    Q2 2024Quarterly · 2024-06-30ProductServices64,500,000USD0001367644-24-000147
    Q1 2024Quarterly · 2024-03-31ProductCommercial Product118,500,000USD0001367644-24-000063
    Q1 2024Quarterly · 2024-03-31ProductContracts And Grants8,000,000USD0001367644-24-000063
    Q1 2024Quarterly · 2024-03-31ProductMedical Countermeasures MCMProduct155,400,000USD0001367644-24-000063
    Q1 2024Quarterly · 2024-03-31ProductServices18,300,000USD0001367644-24-000063
    FY 2023Yearly · 2023-12-31GeographyCanada224,200,000USD0001367644-26-000015
    FY 2023Yearly · 2023-12-31GeographyOther Geographical Area217,900,000USD0001367644-26-000015
    FY 2023Yearly · 2023-12-31GeographyUnited States607,200,000USD0001367644-26-000015
    FY 2023Yearly · 2023-12-31SegmentCommercial Products497,300,000USD0001367644-26-000015
    FY 2023Yearly · 2023-12-31SegmentMCMProducts447,200,000USD0001367644-26-000015
    FY 2023Yearly · 2023-12-31SegmentOther104,800,000USD0001367644-26-000015
    FY 2023Yearly · 2023-12-31ProductCommercial Product497,300,000USD0001367644-25-000021
    FY 2023Yearly · 2023-12-31ProductContracts And Grants26,300,000USD0001367644-25-000021
    FY 2023Yearly · 2023-12-31ProductMedical Countermeasures MCMProduct447,200,000USD0001367644-25-000021
    FY 2023Yearly · 2023-12-31ProductOther5,700,000USD0001367644-25-000021
    FY 2023Yearly · 2023-12-31ProductServices72,800,000USD0001367644-25-000021
    Q3 2023Quarterly · 2023-09-30ProductCommercial Product142,100,000USD0001367644-24-000178
    Q3 2023Quarterly · 2023-09-30ProductContracts And Grants6,500,000USD0001367644-24-000178
    Q3 2023Quarterly · 2023-09-30ProductMedical Countermeasures MCMProduct107,700,000USD0001367644-24-000178
    Q3 2023Quarterly · 2023-09-30ProductOther1,000,000USD0001367644-24-000178
    Q3 2023Quarterly · 2023-09-30ProductServices13,200,000USD0001367644-24-000178
    Q2 2023Quarterly · 2023-06-30ProductContracts And Grants6,600,000USD0001367644-23-000155
    Q2 2023Quarterly · 2023-06-30ProductOther2,700,000USD0001367644-23-000155
    Q2 2023Quarterly · 2023-06-30ProductProduct302,200,000USD0001367644-23-000155
    Q2 2023Quarterly · 2023-06-30ProductServices26,400,000USD0001367644-23-000155
    Q1 2023Quarterly · 2023-03-31ProductCommercial Product106,200,000USD0001367644-24-000063
    Q1 2023Quarterly · 2023-03-31ProductContracts And Grants6,500,000USD0001367644-24-000063
    Q1 2023Quarterly · 2023-03-31ProductMedical Countermeasures MCMProduct37,200,000USD0001367644-24-000063
    Q1 2023Quarterly · 2023-03-31ProductOther1,800,000USD0001367644-24-000063
    Q1 2023Quarterly · 2023-03-31ProductServices12,600,000USD0001367644-24-000063
    FY 2022Yearly · 2022-12-31GeographyCanada148,600,000USD0001367644-25-000021
    FY 2022Yearly · 2022-12-31GeographyOther Geographical Area82,800,000USD0001367644-25-000021
    FY 2022Yearly · 2022-12-31GeographyUnited States886,100,000USD0001367644-25-000021
    FY 2022Yearly · 2022-12-31SegmentCommercial Products386,600,000USD0001367644-25-000021
    FY 2022Yearly · 2022-12-31SegmentMCMProducts579,600,000USD0001367644-25-000021
    FY 2022Yearly · 2022-12-31SegmentOther151,300,000USD0001367644-25-000021
    FY 2022Yearly · 2022-12-31ProductCommercial Product386,600,000USD0001367644-25-000021
    FY 2022Yearly · 2022-12-31ProductContracts And Grants41,400,000USD0001367644-25-000021
    FY 2022Yearly · 2022-12-31ProductMedical Countermeasures MCMProduct579,600,000USD0001367644-25-000021
    FY 2022Yearly · 2022-12-31ProductOther4,900,000USD0001367644-25-000021
    FY 2022Yearly · 2022-12-31ProductServices105,000,000USD0001367644-25-000021
    Q3 2022Quarterly · 2022-09-30ProductContracts And Grants17,400,000USD0001367644-23-000208
    Q3 2022Quarterly · 2022-09-30ProductProduct186,200,000USD0001367644-23-000208
    Q3 2022Quarterly · 2022-09-30ProductServices36,100,000USD0001367644-23-000208
    Q3 2022Quarterly · 2022-09-30GeographyInternational190,200,000USD0001367644-22-000144
    Q3 2022Quarterly · 2022-09-30GeographyUnited States49,800,000USD0001367644-22-000144
    Q2 2022Quarterly · 2022-06-30GeographyInternational118,300,000USD0001367644-22-000119
    Q2 2022Quarterly · 2022-06-30GeographyUnited States124,400,000USD0001367644-22-000119
    Q1 2022Quarterly · 2022-03-31ProductContracts And Grants9,600,000USD0001367644-23-000088
    Q1 2022Quarterly · 2022-03-31ProductOther9,000,000USD0001367644-23-000088
    Q1 2022Quarterly · 2022-03-31ProductProduct237,100,000USD0001367644-23-000088
    Q1 2022Quarterly · 2022-03-31ProductServices51,800,000USD0001367644-23-000088
    Q1 2022Quarterly · 2022-03-31GeographyInternational195,000,000USD0001367644-22-000070
    Q1 2022Quarterly · 2022-03-31GeographyUnited States112,500,000USD0001367644-22-000070
    FY 2021Yearly · 2021-12-31GeographyCanada66,700,000USD0001367644-24-000033
    FY 2021Yearly · 2021-12-31GeographyOther Geographical Area83,500,000USD0001367644-24-000033
    FY 2021Yearly · 2021-12-31GeographyUnited States1,623,400,000USD0001367644-24-000033

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.